Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis

  1. Changchun Xiao1,
  2. Jae-hyuck Shim1,6,
  3. Michael Klüppel5,6,
  4. Samuel Shao-Min Zhang3,6,
  5. Chen Dong1,7,
  6. Richard A. Flavell1,
  7. Xin-Yuan Fu3,
  8. Jeffrey L. Wrana5,
  9. Brigid L.M. Hogan4, and
  10. Sankar Ghosh1,2,8
  1. 1 Section of Immunobiology, Howard Hughes Medical Institute
  2. 2 Department of Molecular Biophysics and Biochemistry, Howard Hughes Medical Institute
  3. 3 Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
  4. 4 Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710, USA
  5. 5 Programme in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada

Abstract

Bone morphogenetic proteins (Bmps) are members of the transforming growth factor β (TGFβ) superfamily that play critical roles during mouse embryogenesis. Signaling by Bmp receptors is mediated mainly by Smad proteins. In this study, we show that a targeted null mutation of Ecsit, encoding a signaling intermediate of the Toll pathway, leads to reduced cell proliferation, altered epiblast patterning, impairment of mesoderm formation, and embryonic lethality at embryonic day 7.5 (E7.5), phenotypes that mimic the Bmp receptor type1a (Bmpr1a) null mutant. In addition, specific Bmp target gene expression is abolished in the absence of Ecsit. Biochemical analysis demonstrates that Ecsit associates constitutively with Smad4 and associates with Smad1 in a Bmp-inducible manner. Together with Smad1 and Smad4, Ecsit binds to the promoter of specific Bmp target genes. Finally, knock-down of Ecsit with Ecsit-specific short hairpin RNA inhibits both Bmp and Toll signaling. Therefore, these results show that Ecsit functions as an essential component in two important signal transduction pathways and establishes a novel role for Ecsit as a cofactor for Smad proteins in the Bmp signaling pathway.

Keywords

Footnotes

  • Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1145603.

  • Supplemental material is available at http://www.genesdev.org.

  • 6 These authors contributed equally to this work.

  • 7 Present address: Department of Immunology, University of Washington, Box 357650, H466 Health Science Complex, Seattle, WA 98195-7650, USA.

  • 8 Corresponding author. E-MAIL sankar.ghosh{at}yale.edu; FAX (203) 785-3855.

    • Accepted October 10, 2003.
    • Received August 20, 2003.
| Table of Contents

Life Science Alliance